Last reviewed · How we verify
NCT06162234: LOVE-WH
Wuhan High Myopia Study
trial testing observational in High Myopia in 1,000 participants. Currently enrolling.
1 September 2027
Quick facts
| Lead sponsor | Renmin Hospital of Wuhan University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 25 December 2023 |
| Primary completion | 1 September 2027 |
| Estimated completion | 1 September 2027 |
| Sites | 1 location across China |
Drugs / interventions tested
- observational — full drug profile →
Conditions studied
- High Myopia — all drugs for High Myopia →
Sponsor
Renmin Hospital of Wuhan University
Who can join
Adults 18 to 65, any sex, with High Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to observe the long-term changes of ocular（especially fundus） structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and prognosis of high myopia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Enlarged Blind Spot Linked to Gamma Zone and Peripapillary Hyperreflective Ovoid Mass-Like Structures in Non-Pathological Highly Myopic Eyes.
Wu Q, Hu R, Liu Q, Li F, et al · · 2025 · cited 1× · PMID 40168151 · DOI 10.1167/iovs.66.4.5
Verify or expand the search:
- PubMed search for NCT06162234
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of observational
Trials testing the same drug.
- NCT06822764 — Mental Processes for Rating Pain Intensity · enrolling by invitation
- NCT06066736 — Risks Factors and Outcome of Recurrences in Patients With Ventilator-Associated Pneumonias (REVAP) · completed
- NCT06403631 — Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis · recruiting
- NCT05768906 — (DIS)AGreement of Relatives Regarding Ethical End-of-life Decisions in ICU. · completed
- NCT05809063 — Characterization, Risk Factors and Outcome of Neonates Admitted to Neonatal Intensive Care Units (NICU) at Sohag Univers · unknown
Other recruiting trials for High Myopia
Currently open trials in the same condition.
- NCT07052825 — The Role of Capsular Tension Rings in Intraocular Lens Stability in High Myopia Cataract Patients: A Prospective Self-Co · NA · recruiting
- NCT06264830 — 3D Visualization System in Highly Myopic Cataract Operation · NA · recruiting
- NCT05850936 — Effect of IOP Lowering on Progressive HM · NA · active not recruiting
- NCT05550740 — Repeated Low-Level Red-Light Therapy for Shortening Axial Length · NA · active not recruiting
- NCT05691296 — The Monitoring and Intervention of Refractive Changes in Children and Teenagers in Tianjin · NA · active not recruiting
Other Renmin Hospital of Wuhan University trials
Trials by the same sponsor.
- NCT07587294 — Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patien · NA · not yet recruiting
- NCT07269509 — Evaluation of the Efficacy and Safety of an Intensified Strategy of Intratonsillar Immunotherapy (ITIT) for Allergic Rhi · NA · not yet recruiting
- NCT07151560 — Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in · Phase 2 · not yet recruiting
- NCT07085221 — Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock · NA · recruiting
- NCT06614985 — The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06162234 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Renmin Hospital of Wuhan University
- Last refreshed: 27 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06162234.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing